Engene to present at the stifel 2025 virtual targeted oncology forum

Boston & montreal--(business wire)--engene holdings inc. (nasdaq: engn or “engene” or the “company”), a clinical-stage, non-viral genetic medicines company, today announced that ron cooper, chief executive officer, will present at the stifel 2025 virtual targeted oncology forum, on tuesday, april 8, 2025, at 4:00 p.m. et. a live webcast of the presentation can be accessed under the “investors” section of the engene website at www.engene.com and will be archived there for 90 days. about engene e.
ENGN Ratings Summary
ENGN Quant Ranking